HAO Haoxi Health Technology Ltd Annual reports only
Services-Advertising Agencies · Nasdaq · SEC CIK 1954594 · Fiscal year ends 06/30
Financial factors as of 2026-06-30 (FY2026), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY67.1%
TTM net income YoY-346.0%
TTM EPS YoY-111.4%
Revenue 3-yr CAGR24.8%
Net income 3-yr CAGR—
Margins
Gross margin1.1%
Operating margin-17.6%
Net margin-17.4%
FCF margin—
EBITDA margin-17.1%
Returns
ROE-54.1%
ROA-44.2%
ROIC (approx.)-93.7%
Asset turnover2.54x
Leverage & solvency
Liabilities / assets17.2%
Debt / equity0.00x
Current ratio4.53x
Interest coverage-184.27x
Cash quality & payout
Operating cash flow / net income0.27x
Accruals ratio-32.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 | FY20242024-06-30 | FY20232023-06-30 | FY20222022-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $54.83M | $32.80M | $48.52M | $28.23M | $16.16M |
| Cost of revenue | $54.20M | $31.88M | $45.77M | $26.17M | $15.51M |
| Gross profit | $629,090 | $927,750 | $2.75M | $2.06M | $648,721 |
| R&D expense | $104,357 | $79,544 | $79,985 | $58,161 | $102,524 |
| SG&A expense | $8.61M | $2.80M | $911,531 | $775,961 | $239,941 |
| Operating income | -$9.66M | -$2.00M | $1.72M | $1.20M | $268,768 |
| Interest expense | $52,446 | $45,956 | $41,186 | $19,775 | — |
| Pretax income | -$9.50M | $4.15M | $1.74M | $1.19M | $259,595 |
| Income tax | $36,614 | $270,744 | $443,582 | $220,653 | $15,008 |
| Net income | -$9.54M | $3.88M | $1.29M | $969,752 | $244,587 |
| EBITDA | -$9.36M | -$1.71M | $1.73M | $1.20M | $270,980 |
| EPS (basic) | -386.40 | 4,251.81 | 2,701.53 | 0.87 | 0.01 |
| EPS (diluted) | -386.40 | 3,385.53 | 2,701.53 | 0.87 | 0.01 |
| Weighted avg. shares (diluted) | 24,680 | 936 | 478 | 1.10M | 25.00M |
| Balance sheet | |||||
| Cash & equivalents | $10.93M | $8.62M | $6.66M | $1.20M | $293,511 |
| Receivables | $5,944 | $460,272 | $226,747 | $7,748 | — |
| Current assets | $16.81M | $19.60M | $15.38M | $3.67M | — |
| PP&E, net | $104,169 | $108,899 | $126,743 | $143,836 | — |
| Intangibles | — | $1.80M | — | — | — |
| Total assets | $21.57M | $21.60M | $15.51M | $4.46M | — |
| Current liabilities | $3.71M | $3.91M | $3.87M | $2.58M | — |
| Short-term debt | $290,710 | $300,338 | $833,521 | $27,344 | — |
| Long-term debt | — | $307,323 | $301,678 | $249,107 | — |
| Total debt | — | $607,661 | $1.14M | $276,451 | — |
| Total liabilities | $3.71M | $4.22M | $4.23M | $2.90M | — |
| Shareholders' equity | $17.86M | $17.38M | $11.27M | $1.57M | -$1.47M |
| Net debt | — | -$8.01M | -$5.52M | -$926,752 | — |
| Cash flow statement | |||||
| Operating cash flow | -$2.57M | -$3.36M | -$747,576 | -$872,132 | -$675,361 |
| Capital expenditure | — | — | $55,367 | $45,500 | $8,698 |
| Free cash flow | — | — | -$802,943 | -$917,632 | -$684,059 |
| Investing cash flow | -$4.50M | -$3.58M | -$3.13M | -$45,500 | -$8,698 |
| Financing cash flow | $9.33M | $8.90M | $9.32M | $1.80M | $933,219 |
| Depreciation & amortization | $308,615 | $294,611 | $10,567 | $8,393 | $2,212 |
| Stock-based compensation | — | $58,602 | — | — | — |
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.